Results 151 to 160 of about 26,203 (316)
Evaluation of Galcanezumab for the Prevention of Episodic Migraine [PDF]
, 2018 Virginia L. Stauffer +5 more
openalex +1 more source
Living With the Fear of Recurrence in Benign Paroxysmal Positional Vertigo
Health Expectations, Volume 29, Issue 1, February 2026.ABSTRACT Background Benign paroxysmal positional vertigo (BPPV) is a common vestibular disorder characterized by brief vertigo episodes. It often leads to functional limitations, psychological distress, and fear of recurrence. Objective The purpose of this phenomenological study was to gain a deep understanding of the lived experiences of patients with
Seo‐Jin Lee, Yujin Hur
wiley +1 more source
Migraine Episodes Following Cranial Irradiation
Pediatric Neurology Briefs, 1995 Complicated migraine-like episodes occurring 1.2 to 2.8 years after cranial irradiation and chemotherapy for brain tumor are reported in four children treated at the Children’s National Medical Center, Washington, DC.
openaire +3 more sources
Journal of Oral Rehabilitation, Volume 53, Issue 2, Page 483-492, February 2026.ABSTRACT Objectives To analyse clinical features and psychological status according to the presence of concomitant headache in a well‐defined group of temporomandibular disorders (TMD). Methods Graded Chronic Pain Scale and Symptom Checklist‐90‐Revision were applied to evaluate pain disability and psychological characteristics in a group of 793 TMD ...
Bo Young Jeong +3 more
wiley +1 more source
Self‐Reported Precipitating and Priming Factors for Somnambulism in Adult Sleepwalkers
Journal of Sleep Research, Volume 35, Issue 1, February 2026.ABSTRACT Several studies have explored how factors that deepen sleep (e.g., sleep deprivation) and factors that fragment sleep (e.g., environmental stimuli) facilitate the occurrence of somnambulistic episodes experienced by sleepwalkers in the sleep laboratory.
Cloé Blanchette‐Carrière +6 more
wiley +1 more source
Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society [PDF]
, 2013 Peer Tfelt‐Hansen
openalex +1 more source
Biologics for episodic and chronic migraines
Canadian Family Physician, 2021 Sandra, Trkulja +3 more
openaire +2 more sources
Clinical Pharmacology in Drug Development, Volume 15, Issue 1, January 2026.Abstract Zavegepant is the only calcitonin gene‐related peptide antagonist approved as a nasal spray in the United States for acute treatment of migraine in adults with or without aura. This Phase 1, open‐label study evaluated the pharmacokinetics, safety, and tolerability of a single intranasal dose of zavegepant 10 mg in 12 healthy Chinese adults ...
Qiong Wei +11 more
wiley +1 more source
Exploratory Pain Profiling With Quantitative Sensory Testing (QST) in Episodic and Chronic Migraine
European Journal of Pain, Volume 30, Issue 1, January 2026.ABSTRACT Background Migraine pain profiling studies vary by sensory modalities, methods, anatomical sites and characteristics. This exploratory study aimed to identify pain profiling parameters using quantitative sensory testing (QST) for episodic migraine (EM) and chronic migraine (CM) and investigate potential differences, given conflicting results ...
Rein F. van Welie +5 more
wiley +1 more source
Phenothiazine Derivatives and Their Impact on the Apoptosis Processes: A Review
Journal of Applied Toxicology, Volume 46, Issue 1, Page 42-60, January 2026.ABSTRACT Phenothiazine derivatives have been used for decades as antipsychotic drugs in multiple mental health and physical conditions treatment (schizophrenia, mania in bipolar disorder, and psychosis). Epidemiological studies have shown that people with schizophrenia are less likely to suffer from cancer, which indicates the ability of antipsychotics
Michał Otręba +4 more
wiley +1 more source